135 related articles for article (PubMed ID: 12431592)
1. Prolongation of xenograft survival by combining donor-specific intravenous presensitization with FK 506.
Iwata H; Umeda Y; Matsuno Y; Yoshikawa S; Marui T; Miyauchi T; Takagi H; Mori Y; Hirose H
Transplant Proc; 2002 Nov; 34(7):2745-8. PubMed ID: 12431592
[No Abstract] [Full Text] [Related]
2. Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506.
Iwata H; Kitagawa S; Sato S; Kosugi A; Hirose H; Hamaoka T; Shearer GM; Fujiwara H
Transplantation; 1993 Jul; 56(1):173-80. PubMed ID: 7687396
[TBL] [Abstract][Full Text] [Related]
3. Topical immunosuppression in skin grafting with FK 506 ointment.
Yuzawa K; Taniguchi H; Seino K; Otsuka M; Fukao K
Transplant Proc; 1996 Jun; 28(3):1387-9. PubMed ID: 8658707
[No Abstract] [Full Text] [Related]
4. Suppression of allograft responses by combining alloantigen-specific i.v. presensitization with suboptimal doses of FK 506 or rapamycin.
Iwata H; Nagano T; Toyo-oka K; Hirose H; Hamaoka T; Fujiwara H
Transplant Proc; 1994 Apr; 26(2):851-4. PubMed ID: 7513476
[No Abstract] [Full Text] [Related]
5. Combination therapy of malononitrilamides and tacrolimus (FK 506) induced long-term xenograft survival.
Schorlemmer HU; Kurrle R
Transplant Proc; 1998 Dec; 30(8):4170-3. PubMed ID: 9865337
[No Abstract] [Full Text] [Related]
6. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
7. Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection.
Fukuzawa M; Okada A
Transplant Proc; 1994 Apr; 26(2):972-4. PubMed ID: 7513483
[No Abstract] [Full Text] [Related]
8. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
9. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
[No Abstract] [Full Text] [Related]
10. Effect of rapamycin on islet and skin xenograft survival.
Bobbio SA; Porter JG; Monaco AP
Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
[No Abstract] [Full Text] [Related]
11. Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model.
Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
Transplant Proc; 1999; 31(1-2):1184-8. PubMed ID: 10083529
[No Abstract] [Full Text] [Related]
12. Prolongation of concordant xenograft survival by treatment with FTY720.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
[No Abstract] [Full Text] [Related]
13. Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft.
Nardo B; Valdivia LA; Catena F; Cavallari G; Demetris AJ; Rao AS; Fung JJ; Starzl TE; Cavallari A
Transplant Proc; 2000 Dec; 32(8):2710-2. PubMed ID: 11134771
[No Abstract] [Full Text] [Related]
14. Acceptance of skin xenografts (from guinea pig to mice) by portal venous and intravenous injections of donor hematolymphoid cells.
Morita H; Sugiura K; Nagahama T; Sakakura Y; Tu W; Oda M; Inoue T; Inui H; Taketani S; Kamiyama Y; Ikehara S
Transplant Proc; 2000 Mar; 32(2):293-4. PubMed ID: 10715422
[No Abstract] [Full Text] [Related]
15. Prolongation of rat to mouse skin and heart xenograft survival by combined CTLA4Ig and anti-CD4/CD8 antibody.
Tu Y; Rehman A; Flye MW
Transplant Proc; 1996 Aug; 28(4):2061-2. PubMed ID: 8769156
[No Abstract] [Full Text] [Related]
16. Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus.
Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
Transplant Proc; 1998 Dec; 30(8):4099-103. PubMed ID: 9865312
[No Abstract] [Full Text] [Related]
17. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
[No Abstract] [Full Text] [Related]
18. Prolongation of concordant xenograft survival by a newly developed drug, FTY720.
Fujiwara I; Nakajima H; Matsuda T; Mizuta N; Yamagishi H; Oka T
Transplant Proc; 1999 Nov; 31(7):2831-3. PubMed ID: 10578306
[No Abstract] [Full Text] [Related]
19. Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation.
Ueno M; Nakajima Y; Segawa M; Hisanaga M; Yabuuchi H; Yoshimura A; Nakano H
Transplant Proc; 1992 Apr; 24(2):638-40. PubMed ID: 1373546
[No Abstract] [Full Text] [Related]
20. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts.
Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N
J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
